Investigating genes of unknown function required for Rickettsia parkeri infection
研究帕氏立克次体感染所需的未知功能基因
基本信息
- 批准号:10724245
- 负责人:
- 金额:$ 6.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-15 至 2025-08-14
- 项目状态:未结题
- 来源:
- 关键词:AdhesionsAffinity ChromatographyAntigensAttenuatedAutophagocytosisBindingBioinformaticsBiologyCRISPR/Cas technologyCellsCellular biologyCollagenComplexCytoskeletonCytosolDefectDevelopmentDiagnosticDissectionEngineeringEnvironmentEquipmentFimbriae ProteinsGenesGeneticGenetic ScreeningGenomeGenomicsGoalsHumanImaging TechniquesInfectionIntegration Host FactorsInvadedInvestigationJointsKnock-outKnowledgeLibrariesLife Cycle StagesLife StyleLinkLipoproteinsMentorshipMethodsMicrobeModelingMutagenesisNaturePathogenesisPathogenicityPathway interactionsPhenotypePositioning AttributeProbabilityProtein SecretionProteinsPublic HealthReportingResearch PersonnelResistanceRickettsiaRickettsia InfectionsRickettsia parkeriRocky Mountain Spotted FeverRoleSurfaceSystemTechniquesTherapeuticTimeTrainingVaccinesVascular DiseasesVirulenceWorkarthropod-bornedesigngene productgenetic approachgenetic manipulationimprovedinnovationmutantnovelnovel therapeuticspathogenpathogenic bacteriareceptor bindingscreeningspatiotemporalspotted fevertherapeutic developmenttool
项目摘要
PROJECT SUMMARY/ABSTRACT
Intracellular bacterial pathogens manipulate host cells through a vast array of mechanisms. Studying these
interactions has propelled our understanding of therapeutic development against these pathogens and host cell
biology. However, many intracellular pathogens cannot be easily studied due to their obligate nature and
resistance to genetic manipulation. These include the spotted fever group (SFG) Rickettsia, which cause a range
of potentially severe arthropod-borne human illnesses, including Rocky Mountain spotted fever. The
development of new random mutagenesis systems for SFG Rickettsia has propelled studies of these microbes
and hinted at the remarkable diversity of unprecedented pathogen innovations in this genus. Recently, our lab
performed a small-scale transposon mutagenesis screen in the model rickettsial species R. parkeri to identify
attenuated mutants. This screen led to the isolation of >100 R. parkeri mutants with infection defects, with only
a few containing insertions in genes previously linked to R. parkeri virulence. The remaining strains represent a
valuable tool for probing and understanding R. parkeri and intracellular pathogen biology. Over 15% of the genes
hit in this screen are unannotated. Two of these unannotated genes, hrtA and sp50, encode R. parkeri proteins
that are predicted to be surface-exposed or secreted and have putative structural features suggestive of direct
binding to host proteins. I hypothesize that HrtA and Sp50 are novel R. parkeri secreted or surface-exposed
effectors that can hijack specific host functions to promote infection. In this proposal, I will first demonstrate the
spatiotemporal niches of both HrtA and Sp50 (Aim 1) to establish how they phenotypically contribute to R. parkeri
infection. Then, I will use affinity purification approaches to identify direct host-derived interactors of HrtA and
Sp50 (Aim 2). Finally, I will use host-direct genetic perturbation screens to profile host-pathogen synthetic genetic
interactions with R. parkeri strains lacking HrtA or Sp50 (Aim 3). Through this work, I will not only extend our
understanding of SFG Rickettsia pathogenesis, but will also demonstrate the potential of a synthetic genetic
approach for investigating and annotating pathogen genes of unknown function. Results from these studies may
also inform development of therapeutics such as vaccines against SFG Rickettsia species.
The training environment at MIT, where this project will be carried out, is outstanding and highly collaborative.
All facilities and equipment required for this project are available to the applicant (Dr. Brandon Sit). The training
plan accompanying this project involves the joint mentorship of Dr. Sit by Drs. Rebecca Lamason (primary
sponsor) and Paul Blainey (co-sponsor), and is designed to position Dr. Sit for a transition to an independent
investigator position at the end of this work.
项目总结/摘要
细胞内细菌病原体通过大量机制操纵宿主细胞。研究这些
相互作用推动了我们对针对这些病原体和宿主细胞的治疗发展的理解
生物学然而,许多细胞内病原体由于其专性性质而不容易研究,
对基因操纵的抵抗这些包括斑点热群(SFG)立克次体,
潜在的严重节肢动物传播的人类疾病,包括落基山斑疹热。的
新的SFG立克次体随机诱变系统的开发推动了对这些微生物的研究
并暗示了该属中前所未有的病原体创新的显着多样性。最近,我们的实验室
进行了一个小规模的转座子诱变筛选的模式立克次体物种R。parkeri识别
减毒突变体该筛选导致>100 R的分离。具有感染缺陷的parkeri突变体,
一些含有先前与R.帕克氏菌毒力其余菌株代表
是探索和理解R. Parkeri和细胞内病原体生物学。超过15%的基因
该屏幕中命中是未注释的。这些未注释的基因中的两个,hrtA和sp 50,编码R。帕克氏蛋白
被预测为表面暴露或分泌的,并具有暗示直接
与宿主蛋白质结合。我推测HrtA和Sp 50是新的R. Parkeri分泌或表面暴露
可以劫持特定宿主功能以促进感染的效应器。在本建议中,我将首先演示
HrtA和Sp 50的时空小生境(目的1),以确定它们如何表型地有助于R。帕克里
感染然后,我将使用亲和纯化方法来鉴定HrtA的直接宿主衍生的相互作用物,
Sp 50(目标2)。最后,我将使用宿主直接遗传干扰筛选来分析宿主-病原体合成遗传干扰。
与R的相互作用缺乏HrtA或Sp 50的parkeri菌株(Aim 3)。通过这项工作,我不仅将扩大我们的
了解SFG立克次体的发病机制,但也将证明合成遗传的潜力,
一种研究和注释功能未知的病原体基因的方法。这些研究的结果可能
还为治疗剂如针对SFG立克次体物种的疫苗的开发提供了信息。
该项目将在麻省理工学院开展,该学院的培训环境非常出色,而且具有高度的协作性。
申请人(布兰登薛博士)可使用本项目所需的所有设施和设备。培训
伴随这个项目的一个计划包括由Rebecca Lamason博士(小学)联合指导Sit博士
发起人)和Paul Blainey(共同发起人),旨在定位薛博士过渡到独立
调查员在这项工作的最后。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Brandon Yiu Chung Sit其他文献
Brandon Yiu Chung Sit的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Brandon Yiu Chung Sit', 18)}}的其他基金
Investigating genes of unknown function required for Rickettsia parkeri infection
研究帕氏立克次体感染所需的未知功能基因
- 批准号:
10535336 - 财政年份:2022
- 资助金额:
$ 6.95万 - 项目类别:
相似海外基金
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10506915 - 财政年份:2021
- 资助金额:
$ 6.95万 - 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10325006 - 财政年份:2021
- 资助金额:
$ 6.95万 - 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
- 批准号:
1746198 - 财政年份:2018
- 资助金额:
$ 6.95万 - 项目类别:
Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
- 批准号:
512537-2017 - 财政年份:2017
- 资助金额:
$ 6.95万 - 项目类别:
University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
- 批准号:
1404605 - 财政年份:2014
- 资助金额:
$ 6.95万 - 项目类别:
Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
- 批准号:
1263713 - 财政年份:2013
- 资助金额:
$ 6.95万 - 项目类别:
Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
- 批准号:
425749-2012 - 财政年份:2012
- 资助金额:
$ 6.95万 - 项目类别:
Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
- 批准号:
1159886 - 财政年份:2012
- 资助金额:
$ 6.95万 - 项目类别:
Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
- 批准号:
19560760 - 财政年份:2007
- 资助金额:
$ 6.95万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
- 批准号:
234753-2000 - 财政年份:2003
- 资助金额:
$ 6.95万 - 项目类别:
Collaborative Research and Development Grants